Sai Ramana Ponugoti appointed as CEO, ICH of Piramal Pharma
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
Consequent to this appointment, Sarosh Shetty ceases to be Interim CEO of ICH.
The order, part of an international framework agreement is to be executed between February to April, 2025
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
The trademark rights for these brands will be transferred to Lupin by March next year.
Brenntag Specialties Pharma marks a strategic milestone with its first collaboration with a contract manufacturer to enhance its nutraceutical value chain
Partnership to supercharge LVMH Recherche with Integrated Biosciences’ innovative AI and synthetic biology platform for targeting skin aging
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
Subscribe To Our Newsletter & Stay Updated